| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/18/2006 | CA2195556C Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 07/18/2006 | CA2194135C Recombinant mono and poly antigens to detect cytomegalovirus-specific igm in human sera by enzyme immunoassay |
| 07/18/2006 | CA2157203C Immunoassay elements having stable leuco dye coatings |
| 07/13/2006 | WO2006074444A2 Enzyme activity measurements using bio-layer interferometry |
| 07/13/2006 | WO2006074419A2 Compounds for inhibiting beta-amyloid production and methods of identifying the compounds |
| 07/13/2006 | WO2006074389A2 Four-helical bundle protein zsig99 |
| 07/13/2006 | WO2006074360A2 Apolipoprotein a-ii isoform as a biomarker for prostate cancer |
| 07/13/2006 | WO2006074350A2 Systems and methods for rapidly changing the solution environment around sensors |
| 07/13/2006 | WO2006074231A2 Improved sample preparation methods for diagnostic analyses |
| 07/13/2006 | WO2006074155A2 Device and method for separating molecules |
| 07/13/2006 | WO2006074144A2 Cell free assay for determining a substance of interest and molecular complexes used therefore |
| 07/13/2006 | WO2006074117A2 Silver/water, silver gels and silver-based compositions; and methods for making and using the same |
| 07/13/2006 | WO2006074076A1 Detecting human antibodies in non-human serum |
| 07/13/2006 | WO2006074074A2 Compositions, methods and kits for real-time enzyme assays using charged molecules |
| 07/13/2006 | WO2006073738A2 Colorimetric sensors constructed of diacetylene materials |
| 07/13/2006 | WO2006073682A2 Diagnostic test |
| 07/13/2006 | WO2006073601A2 Methods and compositions for rna interference |
| 07/13/2006 | WO2006073563A2 Fluorescent affinity tag to enhance phosphoprotein detection |
| 07/13/2006 | WO2006073500A2 Lateral flow system and assay |
| 07/13/2006 | WO2006073465A2 Modified microsurfaces and methods of their manufacture |
| 07/13/2006 | WO2006073441A2 High throughput assays for transmissible spongiform encephalopathies (tse) |
| 07/13/2006 | WO2006073434A2 Phased micro analyzer |
| 07/13/2006 | WO2006073429A2 Entrapped binding protein as biosensors |
| 07/13/2006 | WO2006073424A2 New ultra-sensitive chemiluminescent substrates for enzymes and their conjugates |
| 07/13/2006 | WO2006073421A2 Method for enhancing biological photon receptors using plasmon resonance |
| 07/13/2006 | WO2006073195A1 Method for predicting or diagnosing diabetes and kit for predicting or diagnosing diabetes |
| 07/13/2006 | WO2006073153A1 Simplified assay method for detecting multiple subjects |
| 07/13/2006 | WO2006073133A1 Novel tannase gene and protein thereof |
| 07/13/2006 | WO2006073119A1 Polypeptide and use of the same |
| 07/13/2006 | WO2006073096A1 Fiber product for detecting urine and method of producing the same, diaper and diaper attachment entirely or partly using the fiber product for detecting urine, and diaper rental system with the use of the same |
| 07/13/2006 | WO2006073073A1 Stabilized ornithine transcarbamylase and immunoassay method for ornithine transcarbamylase using the same |
| 07/13/2006 | WO2006073047A1 Biosensor using affinity support having electrolytic cutting ability and method of assaying biological substance |
| 07/13/2006 | WO2006072760A1 Tribology apparatus and method |
| 07/13/2006 | WO2006072710A1 Method for dosing the acidity of hydrocarbons |
| 07/13/2006 | WO2006072708A1 Method and device for determining the smoke point of hydrocarbons |
| 07/13/2006 | WO2006072668A1 Method for analysing a sample |
| 07/13/2006 | WO2006072654A1 Novel genes and markers associated to type 2 diabetes mellitus |
| 07/13/2006 | WO2006072563A2 Hemopexin-like structure as polypeptide-scaffold |
| 07/13/2006 | WO2006072492A1 Gas sensor module |
| 07/13/2006 | WO2006072306A1 Three-dimensional nanostructured and microstructured supports |
| 07/13/2006 | WO2006072166A1 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 07/13/2006 | WO2006050949A3 Superagonistic anti-cd28 antibody |
| 07/13/2006 | WO2006047670A3 Methods for assessing antibodies to neurodegenerative disease-associated antigens |
| 07/13/2006 | WO2006042001A3 Stable three enzyme creatinine biosensor |
| 07/13/2006 | WO2006039717A3 Methods of determining precise herg interactions and altering compounds based on said interactions |
| 07/13/2006 | WO2006039716A3 Methods of determining precise herg interactions by mutagenesis |
| 07/13/2006 | WO2006037495A3 Diagnostics and therapeutics for diseases associated with nuclear receptor subfamily 3, group c, member 2 (nr3c2) |
| 07/13/2006 | WO2006037462A3 Cancer markers |
| 07/13/2006 | WO2006034367A3 Methods and systems for preventing diversion of prescription drugs |
| 07/13/2006 | WO2006034165A3 Methods and systems for providing a nutraceutical program specific to an individual animal |
| 07/13/2006 | WO2006032246A3 Device and method for determining an object parameter |
| 07/13/2006 | WO2006026746A3 Methods to separate and expand antigen-specific t cells |
| 07/13/2006 | WO2006026633A3 Flow sensor with self-aligned flow channel |
| 07/13/2006 | WO2006023398A3 Modular isotope labelled mass spectrometry reagents and methods for quantitation of amino acids, peptides and proteins |
| 07/13/2006 | WO2006021648A9 Multidisciplinary automatic analyser for in vitro diagnosis |
| 07/13/2006 | WO2006017635A3 Isolation, gene expression, and chemotherapeutic resistance of motile cancer cells |
| 07/13/2006 | WO2006015463A3 Soil survey device |
| 07/13/2006 | WO2006015383A3 Biomarkers for diagnosis, prognosis, monitoring, and treatment decisions for drug resistance and sensitivity |
| 07/13/2006 | WO2006011062A3 Printable hydrogel for biosensors |
| 07/13/2006 | WO2006009525A3 P. aeruginosa mucoid exopolysaccharide specific binding peptides |
| 07/13/2006 | WO2006008003A3 Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 1 (vpac1) |
| 07/13/2006 | WO2006007841A3 Heat-induced antigen retrieval methods and compositions therefor |
| 07/13/2006 | WO2006006954A3 Modified fusion peptides derived from a p53 domain against malignant and/or transformed mammalian cells |
| 07/13/2006 | WO2006005583A3 Secreted polypeptide species involved in multiple sclerosis |
| 07/13/2006 | WO2006004598A3 Proteomic analysis |
| 07/13/2006 | WO2006002563A3 Method of assaying for a neurodegenerative disorder in an animal |
| 07/13/2006 | WO2005123243A3 Devices and methods for contacting fluid with a chemical array |
| 07/13/2006 | WO2005112978A3 Methods and compositions related to delivery of chemical compounds to invertebrate embryos |
| 07/13/2006 | WO2005109001A3 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 07/13/2006 | WO2005104754A3 System and method for identifying complex patterns of amino acids |
| 07/13/2006 | WO2005103703A3 Use of novel biomarkers for detection of testicular carcinoma in situ and derived cancers in human samples |
| 07/13/2006 | WO2005100403A3 Antibodies to erythropoietin receptor and uses thereof |
| 07/13/2006 | WO2005094381A3 Universal shotgun assay |
| 07/13/2006 | WO2005083429A3 Breast cancer prognostics |
| 07/13/2006 | WO2005081749A3 Neutralizing human antibodies to anthraxtoxin |
| 07/13/2006 | WO2005079307A3 Use of il-14 derived tools as therapeutics for malignancies and autoimmune diseases and transgenic animals related to same |
| 07/13/2006 | WO2005068991A8 Electrochemical sensor |
| 07/13/2006 | WO2005065277A3 Contamination estimation using fluid analysis models |
| 07/13/2006 | WO2005038409A3 Flow assurance monitoring |
| 07/13/2006 | WO2005033286A3 Compositions and methods for synthesizing, purifying and detecting biomolecules |
| 07/13/2006 | WO2005032454A3 Anti-muc-1 single chain antibodies for tumor targeting |
| 07/13/2006 | WO2005001606A3 Constructing efficient ecosystems using optimization techniques |
| 07/13/2006 | WO2004090100A3 Visualizing expression data on chromosomal graphic schemes |
| 07/13/2006 | WO2004045535A3 Molecular interactions in neurons |
| 07/13/2006 | WO2004010842A3 Lipophilic electrophoretic probes |
| 07/13/2006 | WO2003083073A3 Binding assay employing gpcr 192 |
| 07/13/2006 | WO2003073992A3 Method and composition for detecting early hiv antibody |
| 07/13/2006 | US20060156419 Mouse model for autoimmune disorders |
| 07/13/2006 | US20060155511 Method for monitoring sensor function |
| 07/13/2006 | US20060155486 Computer-implemented system and method for analyzing mixtures of gases |
| 07/13/2006 | US20060155485 Fluid condition monitoring using broad spectrum impedance spectroscopy |
| 07/13/2006 | US20060155484 Ratio-based oligonucleotide probe selection |
| 07/13/2006 | US20060155483 System and process for validating, aligning and reordering one or more genetic sequence maps using at least one ordered restriction map |
| 07/13/2006 | US20060155482 Method for design of polypeptides for nanofabrication of multilayer films, coatings, and microcapsules |
| 07/13/2006 | US20060155478 Method and apparatus for providing signal analysis of a bionems resonator or transducer |
| 07/13/2006 | US20060155403 Systems & methods for realtime determination of asphalt content |
| 07/13/2006 | US20060155200 Method for prediction of cardiac disease |
| 07/13/2006 | US20060155123 Donor dye with absorption maxima at 250-450 nm wavelength; acceptor dye emitting light with maxima greater than 500 nm. in response to absorbing energy emitted by doner; especially with donor and acceptor dyes linked together |
| 07/13/2006 | US20060155115 Multivalent T cell receptor complexes |
| 07/13/2006 | US20060155114 Biosensor; efficiently produced without lowering its function |